Skip to main content
. 2014 Jan 6;58(7):928–936. doi: 10.1093/cid/ciu012

Table 1.

Hepatitis C Global Prevalence by Country (2010)

Country Income Classification Most Prevalent Genotypes Anti-HCVa, % No. Infected
China Upper-middle 1, 2, 6 2.2 29 791 212
India Lower-middle 1, 3 1.5 18 216 960
Egypt Lower-middle 4 14 11 826 360
Indonesia Lower-middle 1, 2 3.9 9 436 986
Pakistan Lower-middle 3 5.9 9 422 402
Russia Upper-middle 1, 3 4.1 5 796 498
United States High 1, 2, 3 1.8 5 367 834
Democratic Republic of Congo Low 4 6.4 4 010 240
Nigeria Lower-middle 1, 2 2.1 3 323 439
Japan High 1, 2 2.4 3 058 008
Cameroon Lower-middle 1, 2, 4 13.8 2 754 204
Brazil Upper-middle 1, 3 1.4 2 609 670
Uganda Low 1, 4 6.6 2 230 536
Philippines Lower-middle 1 2.2 1 932 854
Italy High 1, 2 3.2 1 923 136
Ukraine Lower-middle 1 4.0 1 864 840
Uzbekistan Lower-middle 1, 3 6.5 1 774 955
Turkey Upper-middle 1 2.2 1 549 108
Ethiopia Low 1, 2, 4 1.9 1 500 734
Thailand Upper-middle 1, 3, 6 2.2 1 499 058
World's population 2%–3% 160–180 million

a Prevalence of antibody to hepatitis C virus (HCV).

Sources: Lavanchy [8]; Negro and Alberti [9]. Income classifications from the World Bank, 2013 [43].